Mark Jeffrey Eisenberg
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Mark Jeffrey Eisenberg has a total of 320 co-authors. Here are the top co-authors by number of shared publications:
- Kristian B. Filion
Department of Medicine McGill University Montreal Quebec Canada
44 shared publications Kristian B. Filion
Centre for Clinical Epidemiology, Lady Davis Institute for Medical Research, Montreal, QC, Canada; Department of Epidemiology, Biostatistics and Occupational Health, McGill University, Montreal, QC, Canada; Department of Medicine, McGill University, Montreal, QC, Canada
29 shared publicationsSarah B. Windle
Lady Davis Institute for Medical Research, Jewish General Hospital, Montreal, Canada
27 shared publicationsTetiana Zolotarova
19 shared publicationsAreesha Moiz
18 shared publications- Louise Pilote
Centre for Outcomes Research and Evaluation, Research Institute of McGill University Health Centre, Montreal, Canada
18 shared publications
Latest Publications
- Open Access
- 23 July 2026
- Published by European Publishing in Tobacco Prevention & Cessation
- Vol. 12 (July) , 1-15
Vaping cessation interventions: A narrative review of randomized controlled trials
The increasing prevalence of electronic cigarette (e-cigarette) use, particularly among young individuals, has led to a pressing need for effective vaping cessation interventions. We conducted a narrative review of published and ongoing randomized controlled trials (RCTs) evaluating behavioral,...
- 23 July 2026
- Published by European Publishing in Tobacco Prevention & Cessation
- Vol. 12 (July) , 1-15
Open AccessVaping cessation interventions: A narrative review of randomized controlled trials
The increasing prevalence of electronic cigarette (e-cigarette) use, particularly among young individuals, has led to a pressing need for effective vaping cessation interventions. We conducted a narrative review of published and ongoing randomized controlled trials (RCTs) evaluating behavioral,...
- Open Access
- 28 May 2026
- Published by Elsevier in eClinicalMedicine
- Vol. 96, 103992
Weight maintenance after discontinuation of GLP-1 therapies
- 28 May 2026
- Published by Elsevier in eClinicalMedicine
- Vol. 96, 103992
Open AccessWeight maintenance after discontinuation of GLP-1 therapies
- Open Access
- 25 May 2026
- Published by Elsevier in eClinicalMedicine
- Vol. 96
Balancing the benefits and risks of GLP-1 receptor agonists: a clinical guide for shared decision-making
- 25 May 2026
- Published by Elsevier in eClinicalMedicine
- Vol. 96
Open AccessBalancing the benefits and risks of GLP-1 receptor agonists: a clinical guide for shared decision-making
- Open Access
- 12 May 2026
- Published by Elsevier in The American Journal of Cardiology
- Vol. 272, 77-86
Meta-Analysis of Transcatheter Versus Surgical Aortic Valve Replacement in Low Surgical Risk Patients: An Update
- 12 May 2026
- Published by Elsevier in The American Journal of Cardiology
- Vol. 272, 77-86
Open AccessMeta-Analysis of Transcatheter Versus Surgical Aortic Valve Replacement in Low Surgical Risk Patients: An Update
- 5 May 2026
- Published by Elsevier in The American Journal of Medicine
- Vol. 139 (6) , e177-e178
The Reply
- 5 May 2026
- Published by Elsevier in The American Journal of Medicine
- Vol. 139 (6) , e177-e178
The Reply
- 29 April 2026
- Published by HMP Communications, LLC in Journal of Invasive Cardiology
Extracorporeal Versus Conventional Cardiopulmonary Resuscitation for Out-of-Hospital Cardiac Arrests
It remains unclear whether extracorporeal cardiopulmonary resuscitation (ECPR) is more efficacious than conventional cardiopulmonary resuscitation (CPR) at improving survival with favorable neurological outcomes among patients with out-of-hospital cardiac arrests (OHCA). The authors sought to determine the efficacy of ECPR vs conventional CPR among patients with OHCA in the pre-hospital setting. The authors searched MEDLINE, EMBASE, and the Cochrane Library for randomized controlled trials (RCTs) comparing ECPR with conventional CPR for patients with OHCA. The primary outcome was survival with a favorable neurological outcome at 6-month follow-up. Count data were pooled across trials through random-effects models with inverse variance weighting to estimate risk ratios (RRs) and 95% confidence intervals (CIs). A total of 3 RCTs (n = 420) were included. Most patients (85%) were male, and the mean/median age ranged from 54 to 59 years. At 6 months, 28.4% of the patients randomized to ECPR survived with favorable neurological outcomes compared with 18.6% of the patients randomized to conventional CPR (RR, 1.47; 95% CI, 0.43-5.09). Similar results were obtained for survival at hospital discharge (RR, 1.35; 95% CI, 0.35-5.19). Risk of Bias 2 analysis indicated low risk in 1 trial and some concerns in others. ECPR may be associated with improved survival with favorable neurological outcomes at 6 months compared to conventional CPR for the treatment of OHCA. However, the available evidence remains inconclusive, and additional trials are needed to definitively assess the efficacy of ECPR compared to conventional CPR for OHCA.
- 29 April 2026
- Published by HMP Communications, LLC in Journal of Invasive Cardiology
Extracorporeal Versus Conventional Cardiopulmonary Resuscitation for Out-of-Hospital Cardiac Arrests
It remains unclear whether extracorporeal cardiopulmonary resuscitation (ECPR) is more efficacious than conventional cardiopulmonary resuscitation (CPR) at improving survival with favorable neurological outcomes among patients with out-of-hospital cardiac arrests (OHCA). The authors sought to determine the efficacy of ECPR vs conventional CPR among patients with OHCA in the pre-hospital setting. The authors searched MEDLINE, EMBASE, and the Cochrane Library for randomized controlled trials (RCTs) comparing ECPR with conventional CPR for patients with OHCA. The primary outcome was survival with a favorable neurological outcome at 6-month follow-up. Count data were pooled across trials through random-effects models with inverse variance weighting to estimate risk ratios (RRs) and 95% confidence intervals (CIs). A total of 3 RCTs (n = 420) were included. Most patients (85%) were male, and the mean/median age ranged from 54 to 59 years. At 6 months, 28.4% of the patients randomized to ECPR survived with favorable neurological outcomes compared with 18.6% of the patients randomized to conventional CPR (RR, 1.47; 95% CI, 0.43-5.09). Similar results were obtained for survival at hospital discharge (RR, 1.35; 95% CI, 0.35-5.19). Risk of Bias 2 analysis indicated low risk in 1 trial and some concerns in others. ECPR may be associated with improved survival with favorable neurological outcomes at 6 months compared to conventional CPR for the treatment of OHCA. However, the available evidence remains inconclusive, and additional trials are needed to definitively assess the efficacy of ECPR compared to conventional CPR for OHCA.
- Open Access
- 18 April 2026
- Published by Elsevier in The American Journal of Cardiology
- Vol. 270, 120-123
Argatroban for the Treatment of Acute Ischemic Stroke: A Meta-Analysis of Randomized Controlled Trials
- 18 April 2026
- Published by Elsevier in The American Journal of Cardiology
- Vol. 270, 120-123
Open AccessArgatroban for the Treatment of Acute Ischemic Stroke: A Meta-Analysis of Randomized Controlled Trials
- 20 March 2026
- Published by Elsevier in The American Journal of Medicine
- Vol. 139 (10) , 1275-1276
Live case demonstrations: Enhancing educational value with extended follow-up
- 20 March 2026
- Published by Elsevier in The American Journal of Medicine
- Vol. 139 (10) , 1275-1276
Live case demonstrations: Enhancing educational value with extended follow-up
- 17 March 2026
- Published by Elsevier in The American Journal of Medicine
- Vol. 139 (4) , e123
The reply